{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:41:53Z","timestamp":1771573313582,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1742-4690-10-51","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T19:57:56Z","timestamp":1367956676000},"source":"Crossref","is-referenced-by-count":13,"title":["Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis"],"prefix":"10.1186","volume":"10","author":[{"given":"Mineki","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Arishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujio","family":"Umehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"key":"3430_CR1","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K: Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984, 81: 2534-2537. 10.1073\/pnas.81.8.2534.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3430_CR2","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I: Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981, 78: 6476-6480. 10.1073\/pnas.78.10.6476.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3430_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986, 1: 1031-1032.","journal-title":"Lancet"},{"key":"3430_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985, 2: 407-410.","journal-title":"Lancet"},{"key":"3430_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/13550289609146899","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/ tropical spastic paraparesis. J Neurovirol. 1996, 2: 345-355. 10.3109\/13550289609146899.","journal-title":"J Neurovirol"},{"key":"3430_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M: HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995, 1: 50-61. 10.3109\/13550289509111010.","journal-title":"J Neurovirol"},{"issue":"Suppl","key":"3430_CR7","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1046\/j.1440-1789.2000.00320.x","volume":"20","author":"S Izumo","year":"2000","unstructured":"Izumo S, Umehara F, Osame M: HTLV-I-associated myelopathy. Neuropathology. 2000, 20 (Suppl): S65-68.","journal-title":"Neuropathology"},{"key":"3430_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998, 4: 586-593. 10.3109\/13550289809114225.","journal-title":"J Neurovirol"},{"key":"3430_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13550280390173418","volume":"9","author":"N Takenouchi","year":"2003","unstructured":"Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S: Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 2003, 9: 29-35.","journal-title":"J Neurovirol"},{"key":"3430_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1212\/WNL.41.3.457","volume":"41","author":"M Nomoto","year":"1991","unstructured":"Nomoto M, Utatsu Y, Soejima Y, Osame M: Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis. Neurology. 1991, 41: 457-","journal-title":"Neurology"},{"issue":"Suppl 2","key":"3430_CR11","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1086\/344269","volume":"186","author":"S Jacobson","year":"2002","unstructured":"Jacobson S: Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis. 2002, 186 (Suppl 2): S187-192.","journal-title":"J Infect Dis"},{"key":"3430_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1600-0404.1996.tb07067.x","volume":"94","author":"B Kitze","year":"1996","unstructured":"Kitze B, Usuku K, Yashiki S, Ijichi S, Fujiyoshi T, Nakamura M, Izumo S, Osame M, Sonoda S: Intrathecal humoral immune response in HAM\/TSP in relation to HLA haplotype analysis. Acta Neurol Scand. 1996, 94: 287-293. 10.1111\/j.1600-0404.1996.tb07067.x.","journal-title":"Acta Neurol Scand"},{"key":"3430_CR13","doi-asserted-by":"publisher","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","volume":"8","author":"S Tattermusch","year":"2012","unstructured":"Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O\u2019Garra A, Taylor GP, Bangham CR: Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 2012, 8: e1002480-10.1371\/journal.ppat.1002480.","journal-title":"PLoS Pathog"},{"key":"3430_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-immunol-030409-101243","volume":"28","author":"M Croft","year":"2010","unstructured":"Croft M: Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol. 2010, 28: 57-78. 10.1146\/annurev-immunol-030409-101243.","journal-title":"Annu Rev Immunol"},{"key":"3430_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1349-7006.1996.tb00210.x","volume":"87","author":"N Higashimura","year":"1996","unstructured":"Higashimura N, Takasawa N, Tanaka Y, Nakamura M, Sugamura K: Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I. Jpn J Cancer Res. 1996, 87: 227-231. 10.1111\/j.1349-7006.1996.tb00210.x.","journal-title":"Jpn J Cancer Res"},{"key":"3430_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4049\/jimmunol.165.1.263","volume":"165","author":"R Pankow","year":"2000","unstructured":"Pankow R, Durkop H, Latza U, Krause H, Kunzendorf U, Pohl T, Bulfone-Paus S: The HTLV-I tax protein transcriptionally modulates OX40 antigen expression. J Immunol. 2000, 165: 263-270.","journal-title":"J Immunol"},{"key":"3430_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ijc.2910360506","volume":"36","author":"Y Tanaka","year":"1985","unstructured":"Tanaka Y, Inoi T, Tozawa H, Yamamoto N, Hinuma Y: A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I). Int J Cancer. 1985, 36: 549-555. 10.1002\/ijc.2910360506.","journal-title":"Int J Cancer"},{"key":"3430_CR18","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1002\/j.1460-2075.1994.tb06715.x","volume":"13","author":"PR Baum","year":"1994","unstructured":"Baum PR, Gayle RB, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Baker E, Sutherland GR, Clifford KN: Molecular characterization of murine and human OX40\/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994, 13: 3992-4001.","journal-title":"EMBO J"},{"key":"3430_CR19","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V89.8.2951","volume":"89","author":"A Imura","year":"1997","unstructured":"Imura A, Hori T, Imada K, Kawamata S, Tanaka Y, Imamura S, Uchiyama T: OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration. Blood. 1997, 89: 2951-2958.","journal-title":"Blood"},{"key":"3430_CR20","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","volume":"183","author":"A Imura","year":"1996","unstructured":"Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T: The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med. 1996, 183: 2185-2195. 10.1084\/jem.183.5.2185.","journal-title":"J Exp Med"},{"key":"3430_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm0296-183","volume":"2","author":"AD Weinberg","year":"1996","unstructured":"Weinberg AD, Bourdette DN, Sullivan TJ, Lemon M, Wallin JJ, Maziarz R, Davey M, Palida F, Godfrey W, Engleman E: Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med. 1996, 2: 183-189. 10.1038\/nm0296-183.","journal-title":"Nat Med"},{"key":"3430_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1084\/jem.20021937","volume":"198","author":"S Salek-Ardakani","year":"2003","unstructured":"Salek-Ardakani S, Song J, Halteman BS, Jember AG, Akiba H, Yagita H, Croft M: OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med. 2003, 198: 315-324. 10.1084\/jem.20021937.","journal-title":"J Exp Med"},{"key":"3430_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4049\/jimmunol.162.1.486","volume":"162","author":"LM Higgins","year":"1999","unstructured":"Higgins LM, McDonald SA, Whittle N, Crockett N, Shields JG, MacDonald TT: Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol. 1999, 162: 486-493.","journal-title":"J Immunol"},{"key":"3430_CR24","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1002\/eji.200425141","volume":"34","author":"SV Pakala","year":"2004","unstructured":"Pakala SV, Bansal-Pakala P, Halteman BS, Croft M: Prevention of diabetes in NOD mice at a late stage by targeting OX40\/OX40 ligand interactions. Eur J Immunol. 2004, 34: 3039-3046. 10.1002\/eji.200425141.","journal-title":"Eur J Immunol"},{"key":"3430_CR25","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#","volume":"30","author":"T Yoshioka","year":"2000","unstructured":"Yoshioka T, Nakajima A, Akiba H, Ishiwata T, Asano G, Yoshino S, Yagita H, Okumura K: Contribution of OX40\/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol. 2000, 30: 2815-2823. 10.1002\/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#.","journal-title":"Eur J Immunol"},{"key":"3430_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/01.ATV.0000251007.07648.81","volume":"27","author":"EJ van Wanrooij","year":"2007","unstructured":"van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ, Kuiper J: Interruption of the Tnfrsf4\/Tnfsf4 (OX40\/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2007, 27: 204-210. 10.1161\/01.ATV.0000251007.07648.81.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3430_CR27","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V95.7.2434","volume":"95","author":"N Tsukada","year":"2000","unstructured":"Tsukada N, Akiba H, Kobata T, Aizawa Y, Yagita H, Okumura K: Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood. 2000, 95: 2434-2439.","journal-title":"Blood"},{"key":"3430_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.TP.0000131670.99000.54","volume":"78","author":"AJ Curry","year":"2004","unstructured":"Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM: OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation. 2004, 78: 807-814. 10.1097\/01.TP.0000131670.99000.54.","journal-title":"Transplantation"},{"key":"3430_CR29","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.63.8.3220-3226.1989","volume":"63","author":"K Nagata","year":"1989","unstructured":"Nagata K, Ohtani K, Nakamura M, Sugamura K: Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol. 1989, 63: 3220-3226.","journal-title":"J Virol"},{"key":"3430_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-1759(01)00424-0","volume":"255","author":"L Taylor","year":"2001","unstructured":"Taylor L, Schwarz H: Identification of a soluble OX40 isoform: development of a specific and quantitative immunoassay. J Immunol Methods. 2001, 255: 67-72. 10.1016\/S0022-1759(01)00424-0.","journal-title":"J Immunol Methods"},{"key":"3430_CR31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3899\/jrheum.080120","volume":"35","author":"K Komura","year":"2008","unstructured":"Komura K, Yoshizaki A, Kodera M, Iwata Y, Ogawa F, Shimizu K, Wayaku T, Yukami T, Murata M, Hasegawa M: Increased serum soluble OX40 in patients with systemic sclerosis. J Rheumatol. 2008, 35: 2359-2362. 10.3899\/jrheum.080120.","journal-title":"J Rheumatol"},{"key":"3430_CR32","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1182\/blood-2007-10-115220","volume":"111","author":"K Pichler","year":"2008","unstructured":"Pichler K, Kattan T, Gentzsch J, Kress AK, Taylor GP, Bangham CR, Grassmann R: Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients\u2019 T cells by the viral Tax oncoprotein. Blood. 2008, 111: 4741-4751. 10.1182\/blood-2007-10-115220.","journal-title":"Blood"},{"key":"3430_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0306-9877(93)90111-3","volume":"41","author":"S Ijichi","year":"1993","unstructured":"Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M, Ikegami N, Kashio N, Umehara F, Maruyama I: An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM\/TSP. Med Hypotheses. 1993, 41: 542-547. 10.1016\/0306-9877(93)90111-3.","journal-title":"Med Hypotheses"},{"key":"3430_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2249.1994.tb06538.x","volume":"96","author":"S Daenke","year":"1994","unstructured":"Daenke S, Bangham CR: Do T cells cause HTLV-1-associated disease?: a taxing problem. Clin Exp Immunol. 1994, 96: 179-181.","journal-title":"Clin Exp Immunol"},{"key":"3430_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00005072-199411000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S, Kashio N, Hashimoto K, Usuku K, Sato E, Osame M: Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol. 1994, 53: 617-624. 10.1097\/00005072-199411000-00009.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3430_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M: Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993, 52: 424-430. 10.1097\/00005072-199307000-00010.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3430_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M: Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994, 53: 72-77. 10.1097\/00005072-199401000-00009.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3430_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ana.410400114","volume":"40","author":"T Moritoyo","year":"1996","unstructured":"Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT: Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol. 1996, 40: 84-90. 10.1002\/ana.410400114.","journal-title":"Ann Neurol"},{"key":"3430_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/00005072-199809000-00005","volume":"57","author":"F Umehara","year":"1998","unstructured":"Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1998, 57: 839-849. 10.1097\/00005072-199809000-00005.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3430_CR40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/MMBR.60.4.722-742.1996","volume":"60","author":"KF Copeland","year":"1996","unstructured":"Copeland KF, Heeney JL: T helper cell activation and human retroviral pathogenesis. Microbiol Rev. 1996, 60: 722-742.","journal-title":"Microbiol Rev"},{"key":"3430_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","volume":"15","author":"T Uchiyama","year":"1997","unstructured":"Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997, 15: 15-37. 10.1146\/annurev.immunol.15.1.15.","journal-title":"Annu Rev Immunol"},{"key":"3430_CR42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.38.8.1302","volume":"38","author":"Y Itoyama","year":"1988","unstructured":"Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, Yamamoto N: Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988, 38: 1302-1307. 10.1212\/WNL.38.8.1302.","journal-title":"Neurology"},{"key":"3430_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2169\/internalmedicine.35.195","volume":"35","author":"T Nakamura","year":"1996","unstructured":"Nakamura T, Nishiura Y, Ichinose K, Shirabe S, Tsujino A, Goto H, Furuya T, Nagataki S: Spontaneous proliferation of and cytokine production by T cells adherent to human endothelial cells in patients with human T-lymphotropic virus type I-associated myelopathy. Intern Med. 1996, 35: 195-199. 10.2169\/internalmedicine.35.195.","journal-title":"Intern Med"},{"key":"3430_CR44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002, 2: 725-734. 10.1038\/nri910.","journal-title":"Nat Rev Immunol"},{"key":"3430_CR45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF03401888","volume":"1","author":"T Vartanian","year":"1995","unstructured":"Vartanian T, Li Y, Zhao M, Stefansson K: Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med. 1995, 1: 732-743.","journal-title":"Mol Med"},{"key":"3430_CR46","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K: Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010, 28: 1591-1598. 10.1200\/JCO.2009.25.3575.","journal-title":"J Clin Oncol"},{"key":"3430_CR47","volume-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"M Osame","year":"1990","unstructured":"Osame M: Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. 1990, New York: Raven Press"},{"key":"3430_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.157.1","volume":"157","author":"B Lee","year":"1989","unstructured":"Lee B, Tanaka Y, Tozawa H: Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. Tohoku J Exp Med. 1989, 157: 1-11. 10.1620\/tjem.157.1.","journal-title":"Tohoku J Exp Med"},{"key":"3430_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009, 6: 19-10.1186\/1742-4690-6-19.","journal-title":"Retrovirology"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4690-10-51\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T15:06:25Z","timestamp":1688223985000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-10-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3430"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-10-51","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]},"article-number":"51"}}